Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-26 5:26 pm Purchase | 2025-06-23 | 13G | Mural Oncology plc MURA | Prosight Management, LP | 900,000 5.200% | 900,000 (New Position) | Filing History |
| 2025-05-14 08:30 am Purchase | 2025-03-31 | 13G | MeiraGTx Holdings plc MGTX | Prosight Management, LP | 4,356,571 5.400% | 303,857 (+7.50%) | Filing History |
| 2025-02-12 08:30 am Purchase | 2024-12-31 | 13G | Vincerx Pharma, Inc. VINC | Prosight Management, LP | 111,755 4.990% | 111,755 (New Position) | Filing History |
| 2024-11-13 08:58 am Sale | 2024-09-30 | 13G | ADC Therapeutics S.A. ADCT | Prosight Management, LP | 9,617,531 9.950% | -9,486 (-0.10%) | Filing History |
| 2024-11-13 08:32 am Sale | 2024-09-30 | 13G | Vincerx Pharma, Inc. VINC | Prosight Management, LP | 83,932 5.000% | -40,929 (-32.78%) | Filing History |
| 2024-11-13 08:30 am Purchase | 2024-09-30 | 13G | ADC Therapeutics S.A. ADCT | Prosight Management, LP | 9,627,017 9.960% | 3,155,217 (+48.75%) | Filing History |
| 2024-11-13 08:30 am Purchase | 2024-09-30 | 13G | Shattuck Labs, Inc. STTK | Prosight Management, LP | 6,684,900 14.000% | 1,314,900 (+24.49%) | Filing History |
| 2024-08-16 7:16 pm Purchase | 2024-08-14 | 13G | Shattuck Labs, Inc. STTK | Prosight Management, LP | 5,370,000 11.300% | 2,587,203 (+92.97%) | Filing History |
| 2024-05-03 09:00 am Purchase | 2024-04-25 | 13G | Vincerx Pharma, Inc. VINC | Prosight Management, LP | 124,861 9.100% | 124,861 (New Position) | Filing History |
| 2024-02-13 09:55 am Sale | 2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Prosight Management, LP | 0 0.000% | -948,012 (Position Closed) | Filing History |
| 2024-02-13 09:54 am Purchase | 2023-12-31 | 13G | MeiraGTx Holdings plc MGTX | Prosight Management, LP | 4,052,714 6.400% | 4,052,714 (New Position) | Filing History |
| 2024-02-13 09:50 am Sale | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Prosight Management, LP | 336,533 4.600% | -70,790 (-17.38%) | Filing History |
| 2024-02-13 09:50 am Sale | 2023-12-31 | 13G | NanoString Technologies, Inc. NSTGQ | Prosight Management, LP | 0 0.000% | -3,150,000 (Position Closed) | Filing History |
| 2024-02-13 09:47 am Purchase | 2023-12-31 | 13G | ADC Therapeutics S.A. ADCT | Prosight Management, LP | 6,471,800 8.000% | 6,471,800 (New Position) | Filing History |
| 2024-02-13 09:26 am Sale | 2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Prosight Management, LP | 1,578,263 2.900% | -702,515 (-30.80%) | Filing History |
| 2023-12-29 5:47 pm Purchase | 2023-12-21 | 13G | Shattuck Labs, Inc. STTK | Prosight Management, LP | 2,782,797 5.900% | 2,782,797 (New Position) | Filing History |
| 2023-09-01 08:40 am Purchase | 2023-08-23 | 13G | NanoString Technologies, Inc. NSTGQ | Prosight Management, LP | 3,150,000 6.600% | 3,150,000 (New Position) | Filing History |
| 2023-06-09 8:15 pm Purchase | 2023-05-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Prosight Management, LP | 2,280,778 5.100% | 2,280,778 (New Position) | Filing History |
| 2023-05-12 7:37 pm Purchase | 2023-05-05 | 13G | MeiraGTx Holdings plc MGTX | Prosight Management, LP | 4,080,804 6.900% | 4,080,804 (New Position) | Filing History |
| 2023-04-20 6:20 pm Purchase | 2023-04-11 | 13G | Kezar Life Sciences, Inc. KZR | Prosight Management, LP | 407,323 5.800% | 407,323 (New Position) | Filing History |